OBJECTIVES: The authors sought to describe the association between post-procedural bleeding and long-term recurrent bleeding, major adverse cardiac events (MACE), and mortality among older patients undergoing percutaneous coronary intervention (PCI). BACKGROUND: Bleeding complications after PCI are associated with an increased risk for acute morbidity and long-term mortality, but the association of these bleeding complications with other events is unknown. METHODS: Patients entered into the National Cardiovascular Data Registry (NCDR) CathPCI Registry (n = 461,311; 946 sites) from January 2004 to December 2008 were linked with claims from the Centers for Medicare & Medicaid Services and grouped according to in-hospital post-PCI bleeding. The association between post-PCI bleeding and 1-, 12-, and 30-month readmission for bleeding, MACE, and all-cause mortality was examined with Cox regression that included patient and procedural characteristics using no bleeding as the reference. RESULTS: Overall, 3.1% (n = 14,107) of patients experienced post-PCI bleeding. Patients who bled were older, more often female, had more medical comorbidities, less often received bivalirudin, and more often underwent PCI via the femoral approach. After adjustment, bleeding after the index procedure was significantly associated with readmission for bleeding (adjusted hazard ratios [95% confidence interval]: 1 month, 1.54 [1.42 to 1.67]; 12 months, 1.52 [1.40 to 1.66]; 30 months, 1.29 [1.11 to 1.50]), MACE (1 month, 1.11 [1.07 to 1.15]; 12 months, 1.17 [1.13 to 1.21]; 30 months, 1.12 [1.06 to 1.19]) and all-cause mortality (1 month, 1.32 [1.26 to 1.38]; 12 months, 1.33 [1.27 to 1.40]); 30 months, 1.22 [1.15 to 1.30]). CONCLUSIONS: Post-PCI bleeding complications are associated with an increased risk for short- and long-term recurrent bleeding, MACE, and all-cause mortality. These data underscore the prognostic importance of periprocedural bleeding and the need for identifying strategies to reduce long-term bleeding risk among patients undergoing PCI.
OBJECTIVES: The authors sought to describe the association between post-procedural bleeding and long-term recurrent bleeding, major adverse cardiac events (MACE), and mortality among older patients undergoing percutaneous coronary intervention (PCI). BACKGROUND:Bleeding complications after PCI are associated with an increased risk for acute morbidity and long-term mortality, but the association of these bleeding complications with other events is unknown. METHODS:Patients entered into the National Cardiovascular Data Registry (NCDR) CathPCI Registry (n = 461,311; 946 sites) from January 2004 to December 2008 were linked with claims from the Centers for Medicare & Medicaid Services and grouped according to in-hospital post-PCI bleeding. The association between post-PCI bleeding and 1-, 12-, and 30-month readmission for bleeding, MACE, and all-cause mortality was examined with Cox regression that included patient and procedural characteristics using no bleeding as the reference. RESULTS: Overall, 3.1% (n = 14,107) of patients experienced post-PCI bleeding. Patients who bled were older, more often female, had more medical comorbidities, less often received bivalirudin, and more often underwent PCI via the femoral approach. After adjustment, bleeding after the index procedure was significantly associated with readmission for bleeding (adjusted hazard ratios [95% confidence interval]: 1 month, 1.54 [1.42 to 1.67]; 12 months, 1.52 [1.40 to 1.66]; 30 months, 1.29 [1.11 to 1.50]), MACE (1 month, 1.11 [1.07 to 1.15]; 12 months, 1.17 [1.13 to 1.21]; 30 months, 1.12 [1.06 to 1.19]) and all-cause mortality (1 month, 1.32 [1.26 to 1.38]; 12 months, 1.33 [1.27 to 1.40]); 30 months, 1.22 [1.15 to 1.30]). CONCLUSIONS: Post-PCI bleeding complications are associated with an increased risk for short- and long-term recurrent bleeding, MACE, and all-cause mortality. These data underscore the prognostic importance of periprocedural bleeding and the need for identifying strategies to reduce long-term bleeding risk among patients undergoing PCI.
Authors: Eric D Peterson; David Dai; Elizabeth R DeLong; J Matthew Brennan; Mandeep Singh; Sunil V Rao; Richard E Shaw; Matthew T Roe; Kalon K L Ho; Lloyd W Klein; Ronald J Krone; William S Weintraub; Ralph G Brindis; John S Rumsfeld; John A Spertus Journal: J Am Coll Cardiol Date: 2010-05-04 Impact factor: 24.094
Authors: Freek W A Verheugt; Steven R Steinhubl; Martial Hamon; Harald Darius; Philippe Gabriel Steg; Marco Valgimigli; Steven P Marso; Sunil V Rao; Anthony H Gershlick; A Michael Lincoff; Roxana Mehran; Gregg W Stone Journal: JACC Cardiovasc Interv Date: 2011-02 Impact factor: 11.195
Authors: Shamir R Mehta; Jean-Pierre Bassand; Susan Chrolavicius; Rafael Diaz; John W Eikelboom; Keith A A Fox; Christopher B Granger; Sanjit Jolly; Campbell D Joyner; Hans-Jurgen Rupprecht; Petr Widimsky; Rizwan Afzal; Janice Pogue; Salim Yusuf Journal: N Engl J Med Date: 2010-09-02 Impact factor: 91.245
Authors: Steven P Marso; Amit P Amin; John A House; Kevin F Kennedy; John A Spertus; Sunil V Rao; David J Cohen; John C Messenger; John S Rumsfeld Journal: JAMA Date: 2010-06-02 Impact factor: 56.272
Authors: Gregory Ducrocq; Joshua S Wallace; Gabriel Baron; Philippe Ravaud; Mark J Alberts; Peter W F Wilson; Erik Magnus Ohman; Danielle M Brennan; Ralph B D'Agostino; Deepak L Bhatt; Philippe Gabriel Steg Journal: Eur Heart J Date: 2010-02-24 Impact factor: 29.983
Authors: Roxana Mehran; Alexandra J Lansky; Bernhard Witzenbichler; Giulio Guagliumi; Jan Z Peruga; Bruce R Brodie; Dariusz Dudek; Ran Kornowski; Franz Hartmann; Bernard J Gersh; Stuart J Pocock; S Chiu Wong; Eugenia Nikolsky; Louise Gambone; Lynn Vandertie; Helen Parise; George D Dangas; Gregg W Stone Journal: Lancet Date: 2009-08-28 Impact factor: 79.321
Authors: Sunil V Rao; Fang-Shu Ou; Tracy Y Wang; Matthew T Roe; Ralph Brindis; John S Rumsfeld; Eric D Peterson Journal: JACC Cardiovasc Interv Date: 2008-08 Impact factor: 11.195
Authors: Sameer K Mehta; Andrew D Frutkin; Jason B Lindsey; John A House; John A Spertus; Sunil V Rao; Fang-Shu Ou; Matthew T Roe; Eric D Peterson; Steven P Marso Journal: Circ Cardiovasc Interv Date: 2009-05-08 Impact factor: 6.546
Authors: Alexander C Fanaroff; Pearl Zakroysky; Daniel Wojdyla; Lisa A Kaltenbach; Matthew W Sherwood; Matthew T Roe; Tracy Y Wang; Eric D Peterson; Hitinder S Gurm; Mauricio G Cohen; John C Messenger; Sunil V Rao Journal: Circulation Date: 2019-01-22 Impact factor: 29.690
Authors: Ian J Neeland; Sandeep R Das; DaJuanicia N Simon; Deborah B Diercks; Karen P Alexander; Tracy Y Wang; James A de Lemos Journal: Eur Heart J Qual Care Clin Outcomes Date: 2017-07-01
Authors: Abdulla A Damluji; Karen Bandeen-Roche; Carol Berkower; Cynthia M Boyd; Mohammed S Al-Damluji; Mauricio G Cohen; Daniel E Forman; Rahul Chaudhary; Gary Gerstenblith; Jeremy D Walston; Jon R Resar; Mauro Moscucci Journal: J Am Coll Cardiol Date: 2019-04-23 Impact factor: 24.094
Authors: Eitan A Friedman; Luisa Texeira; Jessica Delaney; Peter E Weeke; Donald R Lynch; Ehab Kasasbeh; Yanna Song; Frank E Harrell; Josh C Denny; Heidi E Hamm; Dan M Roden; John H Cleator Journal: J Thromb Thrombolysis Date: 2016-05 Impact factor: 2.300
Authors: Jordan B Strom; Hector Tamez; Yuansong Zhao; Linda R Valsdottir; Jeptha Curtis; J Matthew Brennan; Changyu Shen; Jeffrey J Popma; Laura Mauri; Robert W Yeh Journal: Am Heart J Date: 2019-03-06 Impact factor: 4.749
Authors: Neil J Wimmer; Frederic S Resnic; Laura Mauri; Michael E Matheny; Thomas C Piemonte; Eugene Pomerantsev; Kalon K L Ho; Susan L Robbins; Howard M Waldman; Robert W Yeh Journal: J Am Heart Assoc Date: 2013-05-24 Impact factor: 5.501